| Date Filed | Type | Description |
| 08/23/2023 |
4
| ABERNETHY MATT (CFO) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 2,132 shares
@ $107.3914, valued at
$229k
|
|
| 08/22/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 02/08/2023 |
4
| ABERNETHY MATT (CFO) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 1,280 shares
@ $105.6667, valued at
$135.3k
Sold 2,030 shares
@ $102.3278, valued at
$207.7k
Sold 12,807 shares
@ $102.4196, valued at
$1.3M
Sold 11,491 shares
@ $102.4013, valued at
$1.2M
Sold 980 shares
@ $104.1939, valued at
$102.1k
|
|
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/09/2022 |
4
| ABERNETHY MATT (CFO) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 2,030 shares
@ $80.804, valued at
$164k
Sold 1,280 shares
@ $80.7782, valued at
$103.4k
Sold 980 shares
@ $79.6506, valued at
$78.1k
|
|
| 02/02/2022 |
4
| ABERNETHY MATT (CFO) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Granted 66,362 options
@ $79.02, valued at
$5.2M
Granted 9,745 restricted stock units
@ $0 |
|
| 12/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/26/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 02/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/02/2020 |
4
| ABERNETHY MATT (CFO) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 1,645 shares
@ $94.6632, valued at
$155.7k
|
|
| 11/16/2020 |
4
| ABERNETHY MATT (CFO) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 2,257 shares
@ $90.7444, valued at
$204.8k
|
|
| 08/07/2020 |
4
| ABERNETHY MATT (CFO) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 2,257 shares
@ $118.8994, valued at
$268.4k
|
|
| 05/11/2020 |
4
| ABERNETHY MATT (CFO) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 15,000 shares
@ $110.2089, valued at
$1.7M
Exercised 15,000 options to buy
@ $73.6, valued at
$1.1M
|
|
| 04/30/2020 |
4
| ABERNETHY MATT (CFO) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 1,741 shares
@ $102.49, valued at
$178.4k
|
|
| 04/28/2020 |
4
| ABERNETHY MATT (CFO) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 1,934 shares
@ $99.5175, valued at
$192.5k
|
|
| 02/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/04/2019 |
4
| ABERNETHY MATT (CFO) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 1,645 shares
@ $116.3285, valued at
$191.4k
|
|
| 02/08/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/06/2018 |
4
| ABERNETHY MATT (CFO) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Sold 1,178 shares
@ $89.9997, valued at
$106k
|
|
| 02/07/2018 |
4
| ABERNETHY MATT (CFO) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Granted 12,250 restricted stock units
@ $0 |
|
| 12/05/2017 |
4
| ABERNETHY MATT (CFO) has filed a Form 4 on NEUROCRINE BIOSCIENCES INC|
Txns:
| Granted 60,000 options
@ $73.6, valued at
$4.4M
Granted 12,500 restricted stock units
@ $0 |
|
| 12/05/2017 |
3
| ABERNETHY MATT (CFO) has filed a Form 3 on NEUROCRINE BIOSCIENCES INC |